WO2001000041A2 - Method of preparing protein agglomerates - Google Patents

Method of preparing protein agglomerates Download PDF

Info

Publication number
WO2001000041A2
WO2001000041A2 PCT/NL2000/000451 NL0000451W WO0100041A2 WO 2001000041 A2 WO2001000041 A2 WO 2001000041A2 NL 0000451 W NL0000451 W NL 0000451W WO 0100041 A2 WO0100041 A2 WO 0100041A2
Authority
WO
WIPO (PCT)
Prior art keywords
protein
agglomerates
gas
spherical
inlet
Prior art date
Application number
PCT/NL2000/000451
Other languages
French (fr)
Other versions
WO2001000041A3 (en
Inventor
Gerard Willem Hofland
Lucas Antonius Maria Van Der Wielen
Geert Jan Witkamp
Original Assignee
Technische Universiteit Delft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Technische Universiteit Delft filed Critical Technische Universiteit Delft
Priority to AU57169/00A priority Critical patent/AU5716900A/en
Publication of WO2001000041A2 publication Critical patent/WO2001000041A2/en
Publication of WO2001000041A3 publication Critical patent/WO2001000041A3/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/14Vegetable proteins
    • A23J3/16Vegetable proteins from soybean
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23JPROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00Working-up of proteins for foodstuffs
    • A23J3/22Working-up of proteins for foodstuffs by texturising
    • A23J3/28Working-up of proteins for foodstuffs by texturising using coagulation from or in a bath, e.g. spun fibres

Definitions

  • the present invention relates to a method for the preparation of protein agglomerates, wherein in an aqueous protein-containing solution having a pH above the iso- electric point of the protein from which agglomerates are to be formed, carbon dioxide is dissolved at elevated pressure, causing the pH of the protein-containing solution to fall until the pH of the solution substantially reaches the iso-electric point of said protein.
  • the object of the present invention is to provide a method for the preparation of high-grade protein agglomerates .
  • the method is characterized in that C0 2 is introduced gradually and under mixing yielding spherical protein agglomerates, after which the pressure is reduced at a limited rate in order to substantially preserve the spherical nature of the protein agglomerates .
  • proteins which may be formed into spherical agglomerates by controlled agglomeration. Such spherical protein agglomerates may be applied in various fields. Whether agglomerates can be formed from a protein depends on a number of factors, which include the solubility of the protein in the solvent and the charge distribution. A person skilled in the art can experimentally examine the suitability without undue effort and in a simple manner. Although some form of mixing is thought to be required, care should be taken to avoid the formation of foam and forces that may destruct spheres that are formed. When mention is made of substantially reaching the iso-electric point (IEP) , this is understood to be a pH equal to the IEP.
  • IEP iso-electric point
  • the deviation allowed depends on the type of protein and the concentration of protein, both of the protein itself and of other proteins present that have a comparable IEP. At higher pro- tein concentrations a larger deviation in pH is allowed.
  • C0 2 is gradually introduced into the solution (limited by the surface area of the liquid-gas interface and the rate of mixing) , even if the liquid is immediately put under a high C0 2 pressure.
  • the rate of mixing is to be limited in such a way that spherical protein agglomerates are not destroyed by shear.
  • the protein content of a spherical protein agglomerate according to the present invention is very high, in general >80% based on the dry weight of an agglomerate .
  • Animal proteins or proteins formed by fermentation processes, such as produced by bacteria, may be used for the protein-containing solution.
  • a vegetable protein-containing solution is used as the protein- containing solution.
  • the vegetable proteins may, for example, be protein derived from wheat, corn, sunflowerseeds, and coconuts, but according to a preferred embodiment the vegetable protein is soya protein.
  • Soya protein is readily and cheaply available but does not always have the properties desired for food technological applications.
  • the two most important proteins can be separated, wherein the protein having the highest iso- electric point also has the highest sulphur content.
  • a soya protein fraction enriched in sulphur- containing amino-acids according to the present invention may find application on a larger scale.
  • spherical (soya) protein agglomerates can be formed having a diameter in the range of 2 to 50 ⁇ m, with a limited variation in particle size.
  • the pH is kept above 5.3.
  • the protein concentration in the protein-containing solution be less than 0.5 g/1.
  • the protein-containing solution contains more than 1 protein, from which proteins protein agglomerates are formed by lowering the pH.
  • spherical protein agglomerates By acidifying the solution using C0 2 strongly and (at least relatively) quickly, spherical protein agglomerates can be formed which are a mixture of the proteins .
  • spherical protein agglomerates By introducing C0 2 step-wise, spherical protein agglomerates can be formed wherein each protein agglomerate is comprised substantially of one protein.
  • protein agglomerates formed from a protein are separated before (at a higher C0 2 pressure) a further protein is formed into protein agglomerates.
  • the invention encompasses stripping a carbon dioxide-containing protein-containing solution to give a solution depleted in carbon dioxide wherein, as a result of stripping, spherical protein agglomerates are formed.
  • This method is suitable for proteins having an iso-electric point around 7 (such as 6 - 8) .
  • a protein may be extracted using a solution which is prepared by introducing carbon dioxide into a slightly basic solution (suitably of a base having a pK b ⁇ 4) . Stripping may be achieved using any method known in the art, such as contacting with a gas low in carbon dioxide, such as nitrogen, which nitrogen enriched in carbon dioxide is discharged.
  • the spherical protein agglomerates formed are stabilized using an agent chosen form the group consisting of i) an acid; and ii) a cross-linking agent.
  • the spherical protein agglomerates may be stabilized by means of drying or, in accordance with the above embodiment, with the aid of an acid.
  • the acid may be an organic or inorganic acid as desired, and for most applications a physiologically acceptable acid.
  • Suitable acids are, for example, acetic acid or hydrochloric acid.
  • the acids are gradually introduced while carbon diox- ide is discharged, keeping the pH substantially constant.
  • the pH is allowed to rise somewhat, such as for example by up to 1 pH unit. In general, smaller increases improve the stability.
  • Use may also be made of cross-linking agents, such as for example glutaric dialdehyde or formaldehyde .
  • the cross-linking agents will also preferably be physiologically acceptable.
  • the invention more generally relates to spherical protein agglomerates, such as spherical soya protein agglomerates, prepared using the method according to the in- vention.
  • spherical protein agglomerates Two important possible applications of the spherical protein agglomerates according to the invention are protein-containing food products and pharmaceutical compositions, including the preparation thereof.
  • the present invention relates to the preparation of protein agglomerates using an apparatus comprising a first container having a first inlet and a first outlet positioned opposite to said first inlet, the first outlet being connected to a second inlet of a second container, which second container further possesses a second outlet positioned opposite to said second inlet, wherein the first container is provided with a first gas inlet for a gas rich in carbon dioxide and a first gas outlet for gas depleted in carbon dioxide positioned opposite to said first gas inlet, and the second container is provided with a second gas inlet for gas low in carbon dioxide and a second gas outlet for a gas enriched in carbon dioxide positioned opposite to the second gas inlet, wherein the (gas) inlets and (gas) outlets are placed such that during operation fluid introduced via an inlet is in countercurrent with gas introduced via a gas inlet .
  • a pump will generally be provided for supplying the protein-containing liquid at an elevated pressure to the first inlet of the first container, and at the same pressure gas rich in carbon dioxide will be supplied via the first gas inlet.
  • the first container is not completely filled with protein- containing liquid and the gas rich in carbon dioxide is introduced in countercurrent above the liquid. Because of the countercurrent operation the gas rich in carbon dioxide is depleted in carbon dioxide, and a rapid decrease in pH of liquid newly introduced into the container is avoided.
  • gas poor in carbon dioxide which includes gas devoid of carbon dioxide, is introduced.
  • This gas takes up carbon dioxide from the liquid introduced via the second inlet, which gas enriched in carbon dioxide is discharged via the second outlet. If desired, this gas may be purified or supplemented with C0 2 and fed to the first gas inlet of the first container.
  • the containers are elongated.
  • Such a mixing can readily be achieved by stirring means rotating perpendicular to the direction of flow. This promotes mixing in the radial direction without much mixing occurring in the axial direction.
  • Fig. l is an electron micrograph of protein ag- glomerates according to the invention.
  • Fig. 2 is an electron microscopic enlargement of a protein agglomerate.
  • Example I The method of Example I was repeated with a 1:1 dilution of the soya flour extract. The difference with the experiment of Example I was that the rotational speed was varied (see table below) .
  • Example I was repeated (using 750 ml 1:1 diluted soya flour extract) at 300 rpm. Immediately after the desired pH was attained, the rotational speed was reduced t 50 rpm. Carbon dioxide in the reactor vessel was elimi nated while maintaining the pressure by supplying nitrogen. Nitrogen was supplied for 5 minutes at a rate of 0.5 litre per minute. By operating this way reduced formation of foam was observed when the pressure was reduced.
  • Example IV
  • Example I The experiment of Example I was repeated (using
  • Soya protein which can be precipitated using acid comprises two main components, i.e. glycinine and ⁇ - conglycinine .

Abstract

The invention relates to a method for the preparation of protein agglomerates, by introducing CO2 in an aqueous protein-containing solution. According to the invention CO2 is gradually and while mixing supplied yielding spherical protein agglomerates, after which the pressure is reduced with a rate such that the spherical nature of the protein agglomerates is substantially maintained. The invention also relates to a food product and a pharmaceutical compound containing such protein preparations.

Description

Method of preparing protein agglomerates, protein agglomerates, and a food product and a pharmaceutical composition in which they are comprised
The present invention relates to a method for the preparation of protein agglomerates, wherein in an aqueous protein-containing solution having a pH above the iso- electric point of the protein from which agglomerates are to be formed, carbon dioxide is dissolved at elevated pressure, causing the pH of the protein-containing solution to fall until the pH of the solution substantially reaches the iso-electric point of said protein.
Such a method is known in the art. Jordan P.J. et al . (J. of Dairy Science and Technology, 22., PP- 247
(1987)) disclose a method for the preparation of a crude casein-agglomerate using carbon dioxide at elevated pressure (3500 kPa (35 Bar) ) . The agglomerate had the appearance of curd and the protein yield was 99%. The object of the present invention is to provide a method for the preparation of high-grade protein agglomerates .
To this end, the method is characterized in that C02 is introduced gradually and under mixing yielding spherical protein agglomerates, after which the pressure is reduced at a limited rate in order to substantially preserve the spherical nature of the protein agglomerates .
Surprisingly it has been found that proteins exist which may be formed into spherical agglomerates by controlled agglomeration. Such spherical protein agglomerates may be applied in various fields. Whether agglomerates can be formed from a protein depends on a number of factors, which include the solubility of the protein in the solvent and the charge distribution. A person skilled in the art can experimentally examine the suitability without undue effort and in a simple manner. Although some form of mixing is thought to be required, care should be taken to avoid the formation of foam and forces that may destruct spheres that are formed. When mention is made of substantially reaching the iso-electric point (IEP) , this is understood to be a pH equal to the
IEP ± 1, but preferably ± 0.6 or less. The deviation allowed depends on the type of protein and the concentration of protein, both of the protein itself and of other proteins present that have a comparable IEP. At higher pro- tein concentrations a larger deviation in pH is allowed. C02 is gradually introduced into the solution (limited by the surface area of the liquid-gas interface and the rate of mixing) , even if the liquid is immediately put under a high C02 pressure. The rate of mixing is to be limited in such a way that spherical protein agglomerates are not destroyed by shear. The protein content of a spherical protein agglomerate according to the present invention is very high, in general >80% based on the dry weight of an agglomerate . Animal proteins or proteins formed by fermentation processes, such as produced by bacteria, may be used for the protein-containing solution. Suitably, a vegetable protein-containing solution is used as the protein- containing solution. Thus it is possible to apply vegetable proteins for a higher grade application. In this respect protein agglomerates in food products may be considered, wherein the spherical nature may contribute to realize improved organoleptic properties. The vegetable proteins may, for example, be protein derived from wheat, corn, sunflowerseeds, and coconuts, but according to a preferred embodiment the vegetable protein is soya protein.
Soya protein is readily and cheaply available but does not always have the properties desired for food technological applications. Using the method according to the present invention, the two most important proteins can be separated, wherein the protein having the highest iso- electric point also has the highest sulphur content. As one of the disadvantages of soya protein is the low sulphur content, a soya protein fraction enriched in sulphur- containing amino-acids according to the present invention may find application on a larger scale. Using the method according to the present invention, spherical (soya) protein agglomerates can be formed having a diameter in the range of 2 to 50 μm, with a limited variation in particle size. According to a preferred embodiment the pH is kept above 5.3.
Thus it is avoided that phytate ends up in the protein agglomerates.
For the production of protein agglomerates having a small diameter, it is preferred that the protein concentration in the protein-containing solution be less than 0.5 g/1.
According to an interesting embodiment, the protein-containing solution contains more than 1 protein, from which proteins protein agglomerates are formed by lowering the pH.
By acidifying the solution using C02 strongly and (at least relatively) quickly, spherical protein agglomerates can be formed which are a mixture of the proteins . By introducing C02 step-wise, spherical protein agglomerates can be formed wherein each protein agglomerate is comprised substantially of one protein.
According to an interesting embodiment therefore, protein agglomerates formed from a protein are separated before (at a higher C02 pressure) a further protein is formed into protein agglomerates.
Thus separated fractions of protein agglomerates can be obtained.
When the protein agglomerates are not removed it is possible to coat them with the second protein. It is also possible to form very large spherical protein agglomerates by using earlier formed protein agglomerates as nucleating material. The invention encompasses stripping a carbon dioxide-containing protein-containing solution to give a solution depleted in carbon dioxide wherein, as a result of stripping, spherical protein agglomerates are formed. This method is suitable for proteins having an iso-electric point around 7 (such as 6 - 8) . Thus a protein may be extracted using a solution which is prepared by introducing carbon dioxide into a slightly basic solution (suitably of a base having a pKb <4) . Stripping may be achieved using any method known in the art, such as contacting with a gas low in carbon dioxide, such as nitrogen, which nitrogen enriched in carbon dioxide is discharged.
According to a preferred embodiment the spherical protein agglomerates formed are stabilized using an agent chosen form the group consisting of i) an acid; and ii) a cross-linking agent.
The spherical protein agglomerates may be stabilized by means of drying or, in accordance with the above embodiment, with the aid of an acid. The acid may be an organic or inorganic acid as desired, and for most applications a physiologically acceptable acid. Suitable acids are, for example, acetic acid or hydrochloric acid. Suitably, the acids are gradually introduced while carbon diox- ide is discharged, keeping the pH substantially constant. The pH is allowed to rise somewhat, such as for example by up to 1 pH unit. In general, smaller increases improve the stability. Use may also be made of cross-linking agents, such as for example glutaric dialdehyde or formaldehyde . The cross-linking agents will also preferably be physiologically acceptable.
The invention more generally relates to spherical protein agglomerates, such as spherical soya protein agglomerates, prepared using the method according to the in- vention.
Two important possible applications of the spherical protein agglomerates according to the invention are protein-containing food products and pharmaceutical compositions, including the preparation thereof.
Finally the present invention relates to the preparation of protein agglomerates using an apparatus comprising a first container having a first inlet and a first outlet positioned opposite to said first inlet, the first outlet being connected to a second inlet of a second container, which second container further possesses a second outlet positioned opposite to said second inlet, wherein the first container is provided with a first gas inlet for a gas rich in carbon dioxide and a first gas outlet for gas depleted in carbon dioxide positioned opposite to said first gas inlet, and the second container is provided with a second gas inlet for gas low in carbon dioxide and a second gas outlet for a gas enriched in carbon dioxide positioned opposite to the second gas inlet, wherein the (gas) inlets and (gas) outlets are placed such that during operation fluid introduced via an inlet is in countercurrent with gas introduced via a gas inlet .
Such an apparatus allows the method to be per- formed continuously. To this end, a pump will generally be provided for supplying the protein-containing liquid at an elevated pressure to the first inlet of the first container, and at the same pressure gas rich in carbon dioxide will be supplied via the first gas inlet. Suitably the first container is not completely filled with protein- containing liquid and the gas rich in carbon dioxide is introduced in countercurrent above the liquid. Because of the countercurrent operation the gas rich in carbon dioxide is depleted in carbon dioxide, and a rapid decrease in pH of liquid newly introduced into the container is avoided. Similarly, in the second container gas poor in carbon dioxide, which includes gas devoid of carbon dioxide, is introduced. This gas, for example nitrogen or air, takes up carbon dioxide from the liquid introduced via the second inlet, which gas enriched in carbon dioxide is discharged via the second outlet. If desired, this gas may be purified or supplemented with C02 and fed to the first gas inlet of the first container. Preferably the containers are elongated.
This provides a simple method of a gradual change in pH, and limits the effect of mixing in the liquid's direction of flow. Mixing occurs in a direction substantially perpendicular to the liquid's direction of flow.
Such a mixing can readily be achieved by stirring means rotating perpendicular to the direction of flow. This promotes mixing in the radial direction without much mixing occurring in the axial direction.
The present invention will now be illustrated with reference to the following non-limiting example and with reference to the drawing in which
Fig. l is an electron micrograph of protein ag- glomerates according to the invention; and
Fig. 2 is an electron microscopic enlargement of a protein agglomerate.
Example I
1 Part by weight of de-fatted soya flour is mixed with 9 parts by weight demineralized water. The mixture is stirred for 30 minutes at 25°C, and the pH is maintained at 9 using 1 M ΝaOH. Subsequently the mixture is centrifuged for 2 hours at 4000 g. The almost clear supernatant is a protein-containing stock solution (protein concentra- tion circa 40 g/1) which is used in a dilution (with water) of 1:200, 1:9 and 1:1 for the preparation of protein agglomerates. 500 ml diluted protein-containing solution is transferred to a pressure vessel (volume 1 1.) . To acidify the diluted protein-containing solution, C02 is in- troduced at 25°C above the liquid. Stirring (tilted blade stirrer; diam. 4.6 cm) occurs such that the formation of foam is substantially avoided. CO- is introduced until the pH=4.8 , as measured using a high pressure pH sensor (Bύchiglas, Uster, Switzerland) . After maintaining this pressure for at least 30 seconds, the pressure is gradually reduced (in respectively 5, 25 and 60 sec). A milky white suspension is obtained, which is diluted 1:100 with 0.07 M sodium acetate pH 4.8. The particle size is deter-
Figure imgf000008_0001
Figure imgf000008_0002
Example IT
The method of Example I was repeated with a 1:1 dilution of the soya flour extract. The difference with the experiment of Example I was that the rotational speed was varied (see table below) .
Figure imgf000009_0001
Figure imgf000009_0006
Figure imgf000009_0003
Figure imgf000009_0004
In all instances analysis using electron microscopy showed spherical particles having the mean particle size indicated in the table. Example III
Example I was repeated (using 750 ml 1:1 diluted soya flour extract) at 300 rpm. Immediately after the desired pH was attained, the rotational speed was reduced t 50 rpm. Carbon dioxide in the reactor vessel was elimi
Figure imgf000009_0005
nated while maintaining the pressure by supplying nitrogen. Nitrogen was supplied for 5 minutes at a rate of 0.5 litre per minute. By operating this way reduced formation of foam was observed when the pressure was reduced. Example IV
Figure imgf000009_0002
The experiment of Example I was repeated (using
constant by controlling the rate at which C02 was discharged while acid was supplied at a constant rate of 8 ml/min. By keeping the pH slightly above the pH set originally for protein agglomeration using C02, further agglomeration was avoided.
The table below shows the course of pressure and pH.
Figure imgf000010_0001
Example VI
Soya protein which can be precipitated using acid comprises two main components, i.e. glycinine and β- conglycinine . The respective iso-electric points are 5.2 and 4.9. Separation took place by supplying C02 up to a to- tal pressure of 1.2 Bar (pH=6) , after which the solution was removed from the reactor vessel and centrifuged using a precipitate rich in glycinine (90% pure) . Subsequently, the pressure was elevated to 5.0 Bar (pH=5.2) and in the same way a precipitate was removed containing a mixture of both acid-precipitable soya proteins. Finally the pressure was raised to 30.6 Bar (pH=4.8), as a result of which a 80% pure β-conglycinine fraction was obtained.

Claims

1. 1. Method for the preparation of protein agglomerates, wherein in an aqueous protein-containing solution having a pH above the iso-electric point of the protein from which agglomerates are to be formed, carbon di- oxide is dissolved at elevated pressure, causing the pH of the protein-containing solution to fall until the pH of the solution substantially reaches the iso-electric point of said protein, characterized, in that that C02 is introduced gradually and under mixing yielding spherical pro- tein agglomerates, after which the pressure is reduced at a limited rate in order to substantially preserve the spherical nature of the protein agglomerates.
2. Method according to claim 1, characterized, in that the protein-containing solution used is a vegetable protein-containing solution.
3. Method according to claim 2, characterized, in that the vegetable protein is soya protein.
4. Method according to claim 2 or 3 , characterized, in that the pH is kept above 5.3. 5. Method according to any of the preceding claims, characterized, in that the protein concentration in the protein-containing solution is less than 0.
5 g/1.
6. Method according to any of the preceding claims, characterized, in that the protein-containing so- lution contains more than 1 protein, which proteins are formed to protein agglomerates by lowering the pH.
7. Method according to claim 6, characterized, in that after forming protein agglomerates from a protein, the protein agglomerates formed are separated before a further protein is formed to protein agglomerates.
8. Method according to any of the preceding claims, characterized, in that the protein agglomerates are stabilized using an agent chosen from the group consisting of i) an acid; and ii) a cross-linking agent.
9. Method according to any of the preceding claims, wherein for the preparation of protein agglomerates using an apparatus comprising a first container having a first inlet and a first outlet positioned opposite to said first inlet, the first outlet being connected to a second inlet of a second container, which second container further possesses a second outlet positioned opposite to said second inlet, wherein the first container is provided with a first gas inlet for a gas rich in carbon dioxide and a first gas outlet for gas depleted in carbon dioxide positioned opposite to said first gas inlet, and the second container is provided with a second gas inlet for gas poor in carbon dioxide and a second gas outlet for a gas enriched in carbon dioxide positioned opposite to the second gas inlet, wherein the (gas) inlets and (gas)outlets are placed such that during operation fluid introduced via an inlet is in countercurrent with gas introduced via a gas inlet .
10. Method according to claim 9, characterized, in that elongated containers are used.
11. Method according to claim 9 or 10, characterized, in that mixing occurs in a direction substantially perpendicular to the direction of movement of the liquid.
12. Spherical protein agglomerates prepared according to any of the claims 1 to 11.
13. Spherical protein agglomerates, characterized, in that the spherical soya protein agglomerates are prepared according to any of the claims 3 to 11.
14. Proteinaceous food product, characterized, in that it contains spherical protein agglomerates according to claim 12 or 13.
15. Pharmaceutical composition comprising a pharmaceutically active compound together with spherical protein agglomerates according to claim 12 or 13.
PCT/NL2000/000451 1999-06-28 2000-06-28 Method of preparing protein agglomerates WO2001000041A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU57169/00A AU5716900A (en) 1999-06-28 2000-06-28 Method of preparing protein agglomerates, protein agglomerates, and a food product and a pharmaceutical composition in which they are comprised

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL1012452 1999-06-28
NL1012452A NL1012452C2 (en) 1999-06-28 1999-06-28 A process for the preparation of protein agglomerates, protein agglomerates, a foodstuff and a pharmaceutical preparation containing them and an apparatus for the preparation of protein agglomerates.

Publications (2)

Publication Number Publication Date
WO2001000041A2 true WO2001000041A2 (en) 2001-01-04
WO2001000041A3 WO2001000041A3 (en) 2002-10-03

Family

ID=19769463

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/NL2000/000451 WO2001000041A2 (en) 1999-06-28 2000-06-28 Method of preparing protein agglomerates

Country Status (4)

Country Link
AR (1) AR024590A1 (en)
AU (1) AU5716900A (en)
NL (1) NL1012452C2 (en)
WO (1) WO2001000041A2 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005087016A1 (en) * 2004-03-15 2005-09-22 Technische Universiteit Delft Method of preparing a protein aggregate and a pharmaceutical composition
US8658385B2 (en) 2007-09-14 2014-02-25 Biosceptre International Limited Purinergic (P2X) receptors in extra-cellular body fluid
US8709425B2 (en) 2001-01-17 2014-04-29 Biosceptre International Limited Antibodies to non-functional P2X7 receptor
US9181320B2 (en) 2007-09-14 2015-11-10 Biosceptre International Limited Peptides for generating an antibody selectively binding to a non-ATP-binding P2X7 receptor but not to an ATP-binding P2X7 receptor
US9566318B2 (en) 2011-07-01 2017-02-14 Biosceptre (Aust) Pty Ltd Combination therapy

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3833463A (en) * 1972-10-26 1974-09-03 Owens Illinois Inc Method of decolorizing waste process liquid discharged by a paper mill
FR2662583A1 (en) * 1990-05-29 1991-12-06 Air Liquide Method and installation for obtaining a milk protein coagulum
US5104674A (en) * 1983-12-30 1992-04-14 Kraft General Foods, Inc. Microfragmented ionic polysaccharide/protein complex dispersions
WO1993007761A1 (en) * 1991-10-25 1993-04-29 The Nutrasweet Company Dry microparticulated protein product
US5322702A (en) * 1992-06-15 1994-06-21 Fmc Corporation Microgranular protein opacifying material
US5330778A (en) * 1988-09-19 1994-07-19 Opta Food Ingredients, Inc. Hydrophobic protein microparticles
EP0823439A1 (en) * 1996-03-29 1998-02-11 Erawan Pharmaceutical Research and Laboratory Company Limited Improvements in or relating to agglomeration of starch
WO1998006279A1 (en) * 1996-08-09 1998-02-19 Gibson Suzanne M Heat-stable protein microparticles and no-shear process for producing same

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3833463A (en) * 1972-10-26 1974-09-03 Owens Illinois Inc Method of decolorizing waste process liquid discharged by a paper mill
US5104674A (en) * 1983-12-30 1992-04-14 Kraft General Foods, Inc. Microfragmented ionic polysaccharide/protein complex dispersions
US5330778A (en) * 1988-09-19 1994-07-19 Opta Food Ingredients, Inc. Hydrophobic protein microparticles
FR2662583A1 (en) * 1990-05-29 1991-12-06 Air Liquide Method and installation for obtaining a milk protein coagulum
WO1993007761A1 (en) * 1991-10-25 1993-04-29 The Nutrasweet Company Dry microparticulated protein product
US5322702A (en) * 1992-06-15 1994-06-21 Fmc Corporation Microgranular protein opacifying material
EP0823439A1 (en) * 1996-03-29 1998-02-11 Erawan Pharmaceutical Research and Laboratory Company Limited Improvements in or relating to agglomeration of starch
WO1998006279A1 (en) * 1996-08-09 1998-02-19 Gibson Suzanne M Heat-stable protein microparticles and no-shear process for producing same

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
BAKER G. ; JOHNSON L.: "Shortenings encapsulated with oilseed proteins" CEREAL CHEMISTRY, Bd. 57, Nr. 4, 1980, Seiten 257-261, XP000884914 *
JORDAN P. ; LAY K.: "Casein precipitation using high pressure carbon dioxide" NEW ZEALAND JOURNAL OF DAIRY SCIENCE AND TECHNOLOGY, Bd. 22, Nr. 3, 1987, Seiten 247-256, XP000889691 in der Anmeldung erw{hnt *
TOMASULA P M ET AL: "PREPARATION OF CASEIN USING CARBON DIOXIDE" JOURNAL OF DAIRY SCIENCE,US,AMERICAN DAIR SCIENCE ASSOCIATION. CHAPAIGN, ILLINOIS, Bd. 78, Nr. 3, 1. M{rz 1995 (1995-03-01), Seiten 506-514, XP000497072 ISSN: 0022-0302 *

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8709425B2 (en) 2001-01-17 2014-04-29 Biosceptre International Limited Antibodies to non-functional P2X7 receptor
WO2005087016A1 (en) * 2004-03-15 2005-09-22 Technische Universiteit Delft Method of preparing a protein aggregate and a pharmaceutical composition
US7777012B2 (en) 2004-03-15 2010-08-17 Technische Universiteit Delft Method of preparing a protein aggregate and a pharmaceutical preparation
US8658385B2 (en) 2007-09-14 2014-02-25 Biosceptre International Limited Purinergic (P2X) receptors in extra-cellular body fluid
US9181320B2 (en) 2007-09-14 2015-11-10 Biosceptre International Limited Peptides for generating an antibody selectively binding to a non-ATP-binding P2X7 receptor but not to an ATP-binding P2X7 receptor
US9566318B2 (en) 2011-07-01 2017-02-14 Biosceptre (Aust) Pty Ltd Combination therapy

Also Published As

Publication number Publication date
AU5716900A (en) 2001-01-31
WO2001000041A3 (en) 2002-10-03
NL1012452C2 (en) 2001-01-02
AR024590A1 (en) 2002-10-16

Similar Documents

Publication Publication Date Title
AU2002342482B2 (en) Continuous process for production of oil seed protein isolate
CN110917064B (en) Preparation method of pumpkin seed protein nanoparticles, pumpkin seed protein nanoparticles and application of pumpkin seed protein nanoparticles
EP1455592B1 (en) Enhanced oil seed protein recovery
EP1434493B2 (en) Flax protein isolate and production
EP0484508B1 (en) Proteinaceous fat substitute
AU2002331497A1 (en) Flax protein isolate and production
WO2001000041A2 (en) Method of preparing protein agglomerates
WO2018197822A1 (en) Improved pea albumins, method for obtaining same and applications thereof
CN108294164B (en) Method and system for industrially preparing 7S protein of soybean protein
AU747211B2 (en) Methods of removing residual solvent from nasal drug delivery compositions
US7186796B2 (en) Method for drying water-borne materials
CN110498932B (en) Casein-pectin-protocatechuic acid ternary complex, and preparation method and application thereof
JPH047661B2 (en)
Tomasula Supercritical Fluid Processing to Control Particle Size of Food Ingredients
CN115721006A (en) Emulsifier composition, emulsifier composition solution, lipophilic food-loaded pickering emulsion and preparation method
CN112176016A (en) Preparation method of bean nano-scale small molecule composite peptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

NENP Non-entry into the national phase in:

Ref country code: JP

DPE2 Request for preliminary examination filed before expiration of 19th month from priority date (pct application filed from 20040101)